Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.

Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.

Bibliographic Details
Main Authors:	Eda Tanrıkulu Şimşek, Batuhan Bayram, Alev Yıldırım, Ahmet Emre Eşkazan
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Translational Oncology
Subjects:	Breast cancer HER-2 Proto-oncogene protein Lymphocytes Monocytes Neoadjuvant treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523322000651

Similar Items

A Mathematical Model for Complete Morphological Regression in Primary Operable HER2-Positive Breast Cancer
by: A. E. Orlov, et al.
Published: (2021-04-01)

Avaliação da imunomarcação da proteína c-kit (CD-117) em tumores mamários caninos
by: André Rebelo Pantoja, et al.
Published: (2020-03-01)

O PROTO-ONCOGENE RAS NO BÓCIO MULTINODULAR
by: Lenara Golbert, et al.
Published: (2022-07-01)

Exploration of tumor growth regression of quinoa and chia oil nanocapsules via the control of PIK3CA and MYC expression, anti-inflammation and cell proliferation inhibition, and their hepatorenal safety in rat breast cancer model
by: Aida I. El makawy, et al.
Published: (2024-01-01)

Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma
by: Rosalvo Zósimo Bispo Júnior, et al.
Published: (2008-01-01)

Predictive value of lymphocyte subsets and lymphocyte-to-monocyte ratio in assessing the efficacy of neoadjuvant therapy in breast cancer
by: Hao Zhang, et al.
Published: (2024-06-01)

Evaluation of Pathologic Complete Response (pCR) to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients with Estrogen Receptor Positive and HER2 Negative and impact of predicting variables on pCR
by: Ramesh Omranipour, et al.
Published: (2020-07-01)

Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis
by: Lin-Yu Xia, et al.
Published: (2024-04-01)

Insertional Oncogenesis by Non-Acute Retroviruses: Implications for Gene Therapy
by: Hung Fan, et al.
Published: (2011-04-01)

A rare case of medullary carcinoma
by: O.Z. Lishchuk, et al.
Published: (2023-10-01)

Familial Medullary Thyroid Cancer: Five-year Review of the Most Frequent Mutations in the RET Gene: An Update
by: Blanca Estela Díaz Castañeda, et al.
Published: (2022-09-01)

A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma
by: Mohammadi Masoumeh, et al.
Published: (2016-11-01)

Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review
by: Elena Orlandi, et al.
Published: (2024-05-01)

Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer
by: V. A. Kostorov, et al.
Published: (2018-07-01)

Stable or at least once HER2-low status during neoadjuvant chemotherapy confers survival benefit in patients with breast cancer
by: Yingying Zhao, et al.
Published: (2024-12-01)

Child with RET proto-oncogene codon 634 mutation
by: Dilek İnce, et al.
Published: (2017-10-01)

Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer
by: Feng Guan, et al.
Published: (2024-09-01)

Correlation of histopathological patterns in cutaneous melanoma with BRAF mutations Correlação de padrões histopatológicos de melanomas cutâneos com mutações BRAF
by: Juliana Elizabeth Jung, et al.
Published: (2010-12-01)

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER
by: S. A. Laptiev, et al.
Published: (2017-06-01)

Clinicopathological Factors Determining the Pathological Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
by: Abdullah Evren YETİŞİR, et al.
Published: (2021-08-01)

Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia Proliferação celular e apoptose em câncer gástrico e metaplasia intestinal
by: Nora Manoukian Forones, et al.
Published: (2005-03-01)

CBL proteins /
by: Tsygankov, Alexander
Published: (c200)

Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
by: Alfredo Colombo, et al.
Published: (2024-07-01)

DeepCBS: shedding light on the impact of mutations occurring at CTCF binding sites
by: Yiheng Wang, et al.
Published: (2024-02-01)

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain
by: Daniel Rayson, et al.
Published: (2022-12-01)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
by: Arafat Tfayli, et al.
Published: (2020-11-01)

Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer
by: Alexis LeVee, et al.
Published: (2023-05-01)

Strategy and Status of Neoadjuvant Therapy for HER2-positive Breast Cancer
by: LIU Yunjiang, et al.
Published: (2024-01-01)

A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance
by: Nicoleta Sinevici, et al.
Published: (2024-06-01)

Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study
by: Lu Liu, et al.
Published: (2023-12-01)

MEDULLARY THYROID CANCER AS PART OF MEN 2B SYNDROME. CASE REPORT
by: L. N. Lyubchenko, et al.
Published: (2015-04-01)

BRAF V600E Mutation in Odontogenic Keratocyst: A Systematic Review and Meta-Analysis
by: Jéssica da Silva Cunha, et al.
Published: (2025-01-01)

Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations
by: Özlem Boybeyi-Türer, et al.
Published: (2016-08-01)

Ciclo celular: mecanismos reguladores e marcadores bioquímicos
by: Silvia H. Rabenhorst, et al.
Published: (2023-06-01)

The Effect of <i>RAS2</i> Gene Mutation in Single Cell Yeast Model
by: Nazela Ahmed Chowdhury, et al.
Published: (2023-03-01)

A Review on the Molecular Pathology of Epithelial Thyroid Tumors
by: Seyedeh Adeleh Razavi, et al.
Published: (2018-10-01)

Intrathecal Amylin and Salmon Calcitonin Affect Formalin Induced c-Fos Expression in the Spinal Cord of Rats
by: Zahra Khoshdel, et al.
Published: (2014-11-01)

The Genetics of Early-Stage Melanoma in a Veteran Population
by: Kevin Cheung, et al.
Published: (2022-05-01)

Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy
by: Hongxia Sun, et al.
Published: (2021-04-01)

Immunohistochemical markers in predicting behavior of bladder urothelial carcinoma
by: Simin Torabinezhad, et al.
Published: (2024-08-01)